Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

Scientists at the VIB-UGent Center for Plant Systems Biology and VIVES University College have developed a new method to ...

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer called glioblastoma, suggests a new preclinical study. The findings offer a new ...

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer ...

We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) stands against other best gene ...

The way DNA folds inside the nucleus of brain cells may hold the key to understanding a devastating form of brain cancer ...

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV ...

In an initial trial, a single dose of a CRISPR gene-editing therapy lowered cholesterol levels without any serious side effects. The “Heart-2” trial – organised by the biotech company Verve ...

"While we maintain our internal focus, our technology platforms—particularly our ViCas ® CRISPR gene-editing platform and ... content, images, videos, licenses, completeness, legality, or ...

"While we maintain our internal focus, our technology platforms—particularly our ViCas ® CRISPR gene-editing platform and ViLNP ® delivery systems—have proven valuable in advancing ...

Verve Therapeutics Inc. shares jumped after the company reported no safety issues in a new study of its gene-editing treatment for people with high cholesterol. The Boston-based company said its ...